stockrowUnited Therapeutics Corporation
UTHR Healthcare Drug Manufacturers Specialty & Generic
United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.
- Revenue
- +4.13%
- EPS
- −21.7%
- Free cash flow
- −63.7%
Quarter to September 2026, against a year earlier
Follow UTHR
Alert me
United Therapeutics Corporation (UTHR) Gross margin
United Therapeutics Corporation's gross margin over the twelve months to 30 September 2026 was 86.3%, down 1.6 percentage points from fiscal 2025 (87.9%). Over the past ten years it has ranged from 87.8% (fiscal 2018) to 95.5% (fiscal 2016); the current reading is higher than 18% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 53.5% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 87.9% | (1.32) |
| FY2024 | 89.2% | 0.30 |
| FY2023 | 88.9% | (3.23) |
| FY2022 | 92.2% | (0.56) |
| FY2021 | 92.7% | 0.02 |
| FY2020 | 92.7% | 0.83 |
| FY2019 | 91.9% | 4.09 |
| FY2018 | 87.8% | (6.08) |
| FY2017 | 93.9% | (1.58) |
| FY2016 | 95.5% | 0.16 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 88.1% | 0.80 |
| Jun 2026 | 87.3% | 4.37 |
| Mar 2026 | 82.9% | (3.98) |
| Dec 2025 | 86.9% | (0.47) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 97.8% |
| UTHR United Therapeutics Corporation | 86.3% |
| ZTS Zoetis Inc. compare | 71.7% |
| TAK Takeda Pharmaceutical Co. compare | 65.9% |
| HLN Haleon PLC Sponsored ADR compare | 62.2% |
| ELAN Elanco Animal Health Incorporated compare | 55.4% |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 53.5% |
| RDY Dr. Reddy's Laboratories Ltd compare | 49.2% |
| VTRS Viatris Inc. compare | 35.3% |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on UTHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement